Sökning: "pharmaceutical firm"

Visar resultat 21 - 25 av 27 uppsatser innehållade orden pharmaceutical firm.

  1. 21. Research on the Determinants of R&D Expenditures : An Empirical Study on Listed Bio-pharmaceutical Companies of U.S.

    Master-uppsats, Handelshögskolan vid Umeå universitet

    Författare :LuLin Liu; [2011]
    Nyckelord :R D expenditures; R D determinants; bio-pharmaceutical industry; U.S. market;

    Sammanfattning : As the increase of competition levels, the ability of generating a continuous stream of innovation occupies an exceptionally important role in the development and manufacturing of companies, especially in bio-pharmaceutical industry in United States. This paper presents an empirical perspective on the nature of innovation of the U.S. LÄS MER

  3. 22. On the Valuation of ‘Big Pharma’s’ Research Pipelines

    Magister-uppsats, Institutionen för ekonomisk och industriell utveckling

    Författare :Martin Löfqvist; [2009]
    Nyckelord :Big Pharma; Clinical Trials; Econometrics; Valuation; Research and Development;

    Sammanfattning : Background: Tougher demands from regulators on drugs efficiency and safety,governmental cost cutting and more complex areas of research, has led to that the importance of the pharmaceutical industry’s research pipelines are increasing. Even though the capital markets views on the pharmaceutical industry and its valuation is changing, the authors is not aware of any prior research that has been conducted on the topic of how the market reacts to clinical trial results or how security analysts valuates product pipelines. LÄS MER

  4. 23. Governing research and development in the pharmaceutical industry - a literature study

    D-uppsats, Handelshögskolan i Stockholm/Institutionen för finansiell ekonomi

    Författare :Lisa Nielsen Englyst; [2008]
    Nyckelord :Corporate governance; Pharmaceutical industry; R D; Innovation;

    Sammanfattning : In the past years there have been a number of media reports of large drug companies having trouble with getting new drugs to the market, and a number of big selling drugs are nearing the end date of the original patent, opening up to competition from generic drug makers. This paper takes a closer look at the incentives to make large investments in pharmaceutical development from the perspective of corporate governance. LÄS MER

  5. 24. Mergers & Acquisitions : Abnormal returns in the pharmaceutical industry

    Kandidat-uppsats, IHH, Nationalekonomi; IHH, Företagsekonomi

    Författare :Erik Stålstedt; Jens Eriksson; [2006]
    Nyckelord :Mergers Acquisitions; Pharmaceutical industry; Shareholders; Arbitrage Pricing Theory; share performance; Pfizer; Bristol-Myers Squibb and GlaxoSmithKline; Arbitrage Pricing Theory; aktieresultat; Pfizer; Bristol-Myers Squibb and GlaxoSmithKline; Sammanslagningar och förvärv; Läkemedelsbranschen; Aktieägare;

    Sammanfattning : Denna uppsats är skriven inom området finansiering och behandlar fenomenet uppköp och företagsförvärv inom läkemedelsbranschen. I uppsatsen undersöker man läkemedelsbranschen och några nyckelaffärer utförda under de senaste fem åren. LÄS MER

  7. 25. Att måla läppstift på grisen: En fallstudie om den interna interaktionen mellan Inköp och Miljö i arbetet mot hållbar utveckling

    D-uppsats, Handelshögskolan i Stockholm/Institutionen för marknadsföring och strategi

    Författare :Martina Andersson; Maria Törmä; [2006]
    Nyckelord :Sourcing; CSR; Internal network; Interaction; Organizational Sustainable development;

    Sammanfattning : During the last years, the importance of sourcing in firms has increased. Globalization, fierce competition and an increased level of outsourcing are common explanations to why firms have highlighted the potential to realize savings and the value creation that the Purchasing department can generate. LÄS MER